Genetic coping mechanisms observed in Leishmania tropica, from the Middle East region, enhance the survival of the parasite after drug exposure
Hedvig Glans, Gabriel M. Matos, Maria Bradley, Tim Downing, Björn Andersson · 2024
Read Genetic coping mechanisms observed in Leishmania tropica, from the Middle East region, enhance the survival of the parasite after drug exposure by Hedvig Glans, Gabriel M. Matos, Maria Bradley, Tim Downing, Björn Andersson (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11614225.txt.
Description
Hedvig Glans and co-authors published a 2024 study on how a skin-disease parasite survives its treatment. Leishmania tropica causes cutaneous leishmaniasis across the Middle East, and antimony drugs sometimes fail. Parasites have a toolkit for coping: extra or missing chromosomes, reshuffled DNA, and variation in gene copies, including one locus tied to drug resistance. The team read the genomes of twenty-two isolates from Afghanistan, Iran, and Syria.
They mapped changes and copy-number patterns against geography, family trees, and drug exposure history. One chromosome stood out: Syrian isolates carried a density of changes on chromosome 23, including the resistance-linked region. The picture is of a parasite that rewrites its genome under drug pressure, using several mechanisms at once. The authors argue clinics should track these tricks, so they know when the old drug has met its match.
Catalog record
| CREATOR | Hedvig Glans, Gabriel M. Matos, Maria Bradley, Tim Downing, Björn Andersson |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |